| Leica Biosystems | |
| Type: | Subsidiary GmbH |
| Location: | Nussloch, Germany |
| Industry: | Biotechnology, Digital pathology |
| Foundation: | 1872, as Precision Engineering |
| Parent: | Danaher Corporation |
| Products: | Microtome; Cryostat; Vibratome, Digital Pathology Scanner |
Leica Biosystems, founded 1872 as Precision Engineering,[1] is a medical devices company that develops and supplies clinical diagnostics to the pathology market. It is also a research, instrument, and medical device company as well as a division of Danaher Corporation.
The company has headquarters in Germany with operations in the United Kingdom, Netherlands, Australia, India, China, Singapore, Mexico, and the United States (California, Illinois, and Ohio). A research and development facility concentrating on companion diagnostics for cancer drugs has been in operation in Danvers, Massachusetts since August 2012.[2] The Massachusetts facility has partnered with Galena Biopharma to develop companion diagnostics for a breast cancer vaccine.[3]
In 2024, Leica Biosystems announced the relocation of its Companion Diagnostics and Advanced Assays business to Newcastle, United Kingdom.[4]
In November 2022, the company announced its acquisition of Cell IDx Inc.[5], headquartered in San Diego, California, and provides multiplex staining panels, tissue staining, and imaging and analysis services.
Leica Biosystems acquired Aperio, an ePathology solutions company, in October 2012.[6] In October 2014, the company announced they will purchase Devicor Medical Products, which is headquartered in Cincinnati and makes medical devices used in breast biopsies.[7]
The company partners with Mayo Clinic’s Department of Laboratory Medicine and Pathology in developing cytogenetics imaging software.[8]